A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults
Clinical trial NCT03357263 · COMPLETED
Trial details
- NCT number
- NCT03357263
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-20
- Primary completion
- 2017-12-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.